health
View full archive →Medicine, public health, biotech, and wellness.
Boston Scientific pursued Watchman sales beyond limited FDA approval, investigation says
An investigation reports that Boston Scientific pursued broader sales of the Watchman cardiac implant after FDA approval for a limited patient group, with more than 800,000 devices implanted worldwide. The story matters because device adoption can move faster than mature evidence, affecting patient safety, costs, and trust.
Nebraska study finds compounded GLP-1 weight-loss prescriptions reached 86% of compounded weight-loss prescriptions in 2025
A JAMA observational study of Nebraska dispensing data found compounded GLP-1 weight-loss prescriptions rose from zero in 2018 to 86% of compounded weight-loss prescriptions in 2025. Many products contained vitamin B12 analogs and levocarnitine, additives marketed for side-effect reduction but not tested in these combinations. The finding matters because cash-pay online use can keep patients and their medications outside routine safety monitoring.
WHO center confirms human-to-human hantavirus spread on cruise ship, killing 3 of 13
A Science study confirmed human-to-human transmission of Andes hantavirus aboard the cruise ship M/V Hondius after 13 passengers developed hantavirus pulmonary syndrome and three died. The findings combine symptom timing, close-contact tracing and viral genome sequencing to show an initial rodent-linked introduction followed by secondary spread. The result strengthens the case for rapid contact tracing and laboratory surveillance in high-density travel settings.
VCU survey finds over half of COVID smell-loss respondents still symptomatic after 5 years
A preliminary VCU survey published in Otolaryngology–Head and Neck Surgery found that more than half of respondents with COVID-19-related smell loss still had symptoms five years later. The report suggests recovery may plateau after two years, with older adults less likely to regain full smell function. It highlights a long tail of sensory impairment affecting safety, nutrition and quality of life.
U.S. communities test phone limits after students describe all-night use and online abuse
A STAT+ report describes homegrown U.S. efforts, including a Milwaukee teacher's project, to reduce teen phone use after students reported secret nighttime use, online abuse and app deletion cycles. The piece highlights community-level responses to digital wellbeing, but the excerpt provides anecdotal evidence rather than clinical or population data. It matters because it shows local actors testing guardrails around attention, sleep and online harm.
PAHO panel weighs stripping U.S. and Mexico of measles elimination status
A PAHO advisory commission is deciding whether measles has been continuously circulating in the United States and Mexico for a year or more, which could strip both countries of elimination status. The finding rests on genetic evidence from outbreaks that have produced thousands of illnesses and about a dozen deaths in the United States. It matters because the designation reflects the durability of vaccination coverage and cross-border outbreak control.
University of Córdoba study of 217 finds perceived health-care discrimination associated with delayed appointments among LGBTQIA+ young adults
A University of Córdoba study of 217 young adults found that perceived health-care discrimination was higher among gay, bisexual, lesbian and trans participants than among cisgender participants and was associated with lower trust and delayed medical care. The research suggests that discrimination in clinical settings can create barriers to diagnosis and treatment. It points to training and protocol gaps rather than deliberate clinician hostility.
International Fertility Group marketed three-parent IVF to women over 35 abroad, investigation finds
An investigation found that International Fertility Group helped clients obtain mitochondrial replacement techniques overseas for infertility, despite absent peer-reviewed human evidence. Published and unpublished data showed weak or no benefit for older women, while clinics marketed the procedure to them. The findings expose gaps in oversight of cross-border reproductive care.
Polls show Black Americans split on MAHA but aligned on toxin, food concerns
Polling cited in a STAT opinion piece shows Black Americans are less likely than white Americans to support MAHA, yet more likely to strongly agree with concerns about environmental toxins, pesticides and ultra-processed foods. The split suggests movement identity, issue concern and institutional trust are separate forces in health politics.
11 states add extra ACA premium aid for 2027 as marketplace costs climb
At least 11 states running their own ACA marketplaces are offering extra premium assistance for 2027 coverage, after enhanced federal credits expired and marketplace premiums rose sharply. The state aid matters because enrollment fell as costs climbed, and plan choices now turn heavily on networks, deductibles, income rules and deadlines.
Clinicians issue guidance for first approved immunotherapy for children 8-17 newly diagnosed with type 1 diabetes
A national clinical group published guidance for using teplizumab in children 8 to 17 newly diagnosed with type 1 diabetes after FDA expanded approval. In the PROTECT trial, 95 percent of treated participants maintained meaningful insulin production at 78 weeks versus about 79 percent with placebo. The guidance matters because it adds a disease-modifying option at diagnosis, though approval rests on a biomarker rather than proven long-term clinical outcomes.
American Cancer Society updates prostate screening, urging PSA tests every two years for average-risk men 50 to 69
The American Cancer Society now recommends PSA screening every two years for average-risk men 50 to 69 and yearly starting at 45 for higher-risk groups, reversing its 2010 stance. The update aims to catch more prostate cancers earlier while using MRI, biomarkers, and active surveillance to limit overdiagnosis and overtreatment. It matters because screening can trigger costly follow-up and treatment, and Black men face disproportionate prostate cancer mortality.
Arizona State University mouse study finds high-fat diet leaves 18% of DNA changes in intestinal stem cells
A mouse study reports that a high-fat diet can alter intestinal stem cells and leave persistent DNA regulatory changes, with about 18% remaining after four weeks of low-fat diet. The work adds a mechanistic explanation for the link between obesity-related diet and colon cancer risk, while showing that the evidence is from animal models rather than human trials.
New Documents Intensify Scrutiny of Medicare's AI Prior-Authorization Experiment
New documents have intensified scrutiny of Medicare's artificial intelligence prior-authorization experiment. The documents concern oversight of algorithmic decisions that can approve or deny covered services. The issue matters because opaque AI denials can make care harder to obtain and harder to appeal.
Curtin-led meta-analysis links type 2 diabetes to 53% higher Alzheimer's risk
A Curtin University-led systematic review and meta-analysis of 40 studies found that people with type 2 diabetes had a 53% higher adjusted relative risk of Alzheimer's disease, with an estimated 4.7 new cases per 1,000 people with diabetes each year. The analysis strengthens the link between metabolic and neurological disease but, as an observational synthesis, cannot prove causation.
Biotech Companies Rethink Drug Launches Abroad Under Most-Favored-Nation Pricing Policy
Drugmakers are reassessing foreign drug launches under a most-favored-nation pricing policy, according to a STAT report. The issue matters because global pricing rules could change where and when new therapies reach patients. The publicly visible source did not provide detailed company plans or figures.
Air ambulance firm PHI Health sues hundreds of employers over unpaid out-of-network bills
PHI Health's lawsuits against hundreds of employers escalate a fight over unpaid out-of-network emergency bills awarded under the No Surprises Act. The suits could move liability from insurers to employers, raising litigation costs and potentially increasing health premiums. The outcome depends on how courts interpret employer responsibility for arbitration awards.
Former Eli Lilly sales rep files Texas lawsuit alleging retaliation over Mounjaro off-label marketing complaint
A former Eli Lilly sales rep has sued, claiming retaliation after she objected to alleged off-label promotion of Mounjaro for weight loss. The case matters because it tests compliance and whistleblower protections in the fast-growing GLP-1 market, where demand can outpace approved indications. It remains an unproven allegation unless supported by evidence in litigation or regulatory action.
PAHO committee opens U.S. measles elimination review after at least eight deaths this year
A PAHO verification committee has begun a four-day review of whether the United States still meets measles-elimination criteria, after years of rising cases and at least eight deaths this year. The decision classifies transmission; the pattern is consistent with gaps in coverage and outbreak control, not a change in the virus. Losing a status held since 2000 would mark a failure of delivery and confidence with consequences for later outbreak readiness.
Nature study finds millions of obesity diagnoses would flip if a health-based definition replaced BMI
A Nature analysis finds that a Lancet commission’s health-based definition of obesity would move millions of people onto or off the diagnosis relative to BMI. Because that label still controls access to drugs, surgery, and coverage, the reclassification is a policy event as much as a scientific one. The design can estimate how labels shift; it cannot show that patients live longer or have fewer heart attacks.